Latest News and Press Releases
Want to stay updated on the latest news?
-
HONG KONG, April 21, 2026 (GLOBE NEWSWIRE) -- AIOS Tech Inc. (Nasdaq: AIOS) (the “Company”) today announced that its board of directors approved on March 26, 2026, a 20-for-1 share consolidation...
-
BELTSVILLE, Md., April 21, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and...
-
Washington, DC, April 21, 2026 (GLOBE NEWSWIRE) -- Experienced Pilots Advancing Safety (EPAS) issued a statement regarding recent actions by Chinese authorities and their potential implications for...
-
SHANGHAI und STUTTGART, Deutschland, April 21, 2026 (GLOBE NEWSWIRE) -- Der Batteriespeicher- und Wechselrichterspezialist Sigenergy baut seine Marktpräsenz in Deutschland weiter aus: Ab sofort sind...
-
CEO delivered a keynote address on applications of AI and blockchain in intelligent mobilityCompany discussed the potential role of Web3 and AI in supporting long-term innovation and shareholder value...
-
National Center on Education and the Economy (NCEE) Announces the Global “Rapid Risers” in Education
WASHINGTON, D.C., April 21, 2026 (GLOBE NEWSWIRE) -- The National Center on Education and the Economy (NCEE) today announced Georgia, Macao, Oman, Peru, and Qatar as its 2026 Global Rapid Risers....
-
MUSCAT, Oman and LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Asyad Group, a global integrated logistics provider, and Ligentia Group, a premier UK-based tech-enabled supply chain services provider,...
-
Hong Kong, April 21, 2026 (GLOBE NEWSWIRE) -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), Hong Kong’s...
-
BEIJING, China, April 21, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it will...
-
ICP-B794 demonstrated potent anti-tumor activity in preclinical tumor models and a significantly larger safety window compared to similar drugs.